Skip to content
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • COVID-19
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • CHEN LAB
    • Dai Lab
    • Gelfand Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • COVID-19
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • CHEN LAB
    • Dai Lab
    • Gelfand Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • COVID-19
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • CHEN LAB
    • Dai Lab
    • Gelfand Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • COVID-19
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • CHEN LAB
    • Dai Lab
    • Gelfand Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • NEWS
  • DONATE

It’s not over when the vaccine arrives

  • Posted on July 28, 2020

Mark Poznansky interviewed for a report on Axios.com by Alison Snyder and Sam Baker

View Via Axios.com
FacebookTwitter

Recommended Posts

Vaccine and Immunotherapy Center MGH 2020 Holiday Newsletter
Remote Student Internship experiences at VIC during the unprecedented summer of 2020
COVID-19 infections trouble ships as companies try pandemic cruising in Europe, Tahiti
Production, deployment among challenges when COVID-19 vaccine ready
Vaccine & Immunotherapy Center
Accelerating discovery and development of new products addressing unmet clinical need.
Facebook-f
Twitter
Youtube

INFORMATION

  • CAREERS
  • Directions
  • Advisors
  • Management
  • Collaborators
  • Support VIC

CONTACT

149 13th Street, 5th Floor
Charlestown Navy Yard,
MA 02129-2020

Phone  :  1-617-643-2098
Email    :  VIC@partners.org

© 2019 VACCINE & IMMUNOTHERAPY CENTER. ALL RIGHTS RESERVED |  Site by OLP